In mice, the immune response mounted against tuberculosis prevents them from developing COVID-19, according to a new study by Richard Robinson at The Ohio State University, U.S. and colleagues publishing March 24th in the open-access journal PLOS Pathogens.

Tuberculosis (TB) is a potentially serious infectious disease caused by a type of bacterium called Mycobacterium tuberculosis. The bacteria usually affect the lungs, but also can invade other organs.

Researchers from the faculty of medicine at the University of Ottawa and their international collaborators say they have shown proof-of-concept for a new therapeutic approach in treating tuberculosis (TB). The disease is caused by a bacterium, Mycobacterium tuberculosis, that infects the lungs and is highly transmissible when infected people cough or sneeze.

The Global Coalition of TB Advocates, Women4GlobalFund and TB Women Global call for a gender transformative programming within TB responses.

Community monitoring mechanism highlights the gaps in the existing isoniazid preventive therapy program in the country and clearly indicates the high demand for 3HP.

Concomitant treatment with bedaquiline and delamanid (Bdq-Dlm) was determined to be safe and effective and did not increase the risk for cardiotoxicity in patients with multidrug- and rifampicin-resistant (MDR/RR) tuberculosis (TB) infection, according to results of a study published in Clinical Infectious Diseases.

Worldwide, tuberculosis (TB) remains a significant cause of disease and deaths. Around 9.9 million people had the disease in 2020. The burden is higher in low- and middle-income countries. Africa accounts for 25% of TB cases.

Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder of 2022. 

The #RightToPreventTB campaign focuses attention on the urgent need to scale-up TB preventive treatment as a matter of human rights.

Experts urge the international community to ensure continuity of TB and health services for war-affected Ukraine.